Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease—following the fate of anti‐TNF‐alpha agents?

Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease—following the fate of anti‐TNF‐alpha agents?

Linked Content This article is linked to Yacoub et al paper. To view this article visit https://doi.org/10.1111/apt.14548.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2018-05, Vol.47 (9), p.1323-1324
Hauptverfasser: Fragaki, M., Karmiris, K.
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies, Monoclonal, Humanized
Humans
Inflammatory Bowel Diseases
Intestine
Prospective Studies
Tumor necrosis factor
Tumor Necrosis Factor-alpha
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linked Content This article is linked to Yacoub et al paper. To view this article visit https://doi.org/10.1111/apt.14548.
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.14588